
Friday, December 16, 2022 4:13:23 PM


Liked By
Spread the love. Be the first to like this post!
Recent TNXP News
- Annual Report to Security Holders (ars) • Edgar (US Regulatory) • 03/29/2023 10:08:14 AM
- Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress • GlobeNewswire Inc. • 03/27/2023 11:00:00 AM
- Tonix Pharmaceuticals Presents Non-Clinical Data on TNX-2900 for the Potential Treatment of Hyperphagia in Adolescents and Young Adults with Prader-Willi Syndrome at the Rare Disease Innovation and Partnership Summit • GlobeNewswire Inc. • 03/23/2023 08:15:00 PM
- Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia • GlobeNewswire Inc. • 03/23/2023 11:00:00 AM
- Tonix Pharmaceuticals to Present at the 2023 Virtual March Investor Summit • GlobeNewswire Inc. • 03/22/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/20/2023 09:09:22 PM
- Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit • GlobeNewswire Inc. • 03/16/2023 08:05:00 PM
- Tonix Pharmaceuticals Initiates Enrollment in Phase 2 ‘UPLIFT’ Study of TNX-601 ER (Tianeptine Hemioxalate Extended-Release Tablets) for the Treatment of Major Depressive Disorder (MDD) • GlobeNewswire Inc. • 03/16/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 09:29:55 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 11:07:01 AM
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- Tonix Pharmaceuticals Announces Results from a Preclinical Study of Murine TNX-1700 Presented in a Poster at the Keystone Symposia, “Cancer Immunotherapy: Mechanisms of Response Versus Resistance” • GlobeNewswire Inc. • 03/07/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 12:03:12 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:39:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:39:08 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:38:13 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:35:15 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/23/2023 09:23:39 PM
- Tonix Pharmaceuticals Announces New Board Member, R. Newcomb Stillwell • GlobeNewswire Inc. • 02/23/2023 09:15:00 PM
- Tonix Pharmaceuticals Describes Emerging Research on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients During Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?” • GlobeNewswire Inc. • 02/22/2023 12:00:00 PM
- Tonix Pharmaceuticals to Participate in Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?” • GlobeNewswire Inc. • 02/16/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:02:00 PM
- New to The Street Announces its Line-up, Four Interviews on Episode #438, Airing on the Fox Business Network, Tonight, Monday, February 13, 2023, 10:30 PM PT • GlobeNewswire Inc. • 02/13/2023 02:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/13/2023 12:06:31 PM
- Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Fully Human and Murine Anti-SARS-CoV-2 Monoclonal Antibodies • GlobeNewswire Inc. • 02/13/2023 12:00:00 PM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
PSYC's CEO to Moderate Panel at Film Screening for ESPN's Upcoming Documentary, "Peace of Mind" • PSYC • Mar 29, 2023 8:30 AM
Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • USHA • Mar 28, 2023 8:26 AM
Edison Lithium Provides Update on Spin-Out of Cobalt Assets • EDDY • Mar 28, 2023 8:09 AM
Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • EPAZ • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM